ABERRANT POST-TRANSLATIONAL MODIFICATIONS(PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS
US Application 17/923,394
Filed on 2022-11-04
Filed on 2022-11-04
SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA
US Application 17/766,067
Filed on 2022-04-01
Filed on 2022-04-01
SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA
European Patent
20804709.2
Filed on 2022-04-26
20804709.2
Filed on 2022-04-26
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
Japan
2022-000125
Filed on 2022-01-04
2022-000125
Filed on 2022-01-04
CANCER DETECTION AND CLASSIFICATION
US Application 17/632,783
Filed on 2022-02-03
Filed on 2022-02-03
NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA
Hong Kong
62021044683.2
Filed on 2021-12-16
62021044683.2
Filed on 2021-12-16
NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA
Hong Kong
62021042143.9
Filed on 2021-11-09
62021042143.9
Filed on 2021-11-09
Targeted Integration Into The Albumin (Alb) Locus As A Treatment For Hereditary Methylmalonic Acidemia (MMA) Caused By Methylmalonyl-coA Mutase (MUT) Deficiency
South Korea
10-2021-7007207
Filed on 2018-10-30
10-2021-7007207
Filed on 2018-10-30
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
US Patent 11,802,283
Filed on 2020-09-17
Filed on 2020-09-17